Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BVMed proposes wound care law amendments:

This article was originally published in Clinica

Executive Summary

Even though modern wound care products are a proven means of saving costs in the long run, they are often rejected simply because of the initial price per item, says Joachim Schmitt, director of the German medical device industry association (BVMed). Speaking at a press conference of the German association for wound care, he said that traditional wound care products lead to longer healing times for patients, which in turn lead to higher costs for the health insurers. Among the proposals put forward by Mr Schmitt to promote the use of innovative products were the removal or easing of budgeting applied to procedures for the treatment of chronic wounds, and the inclusion of chronic wound care products in a special category for reimbursement.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT071817

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel